ARTICLE SUMMARY:
What’s the value of build-to-buy for medtech? Read our conversation with Chris Eso, who oversees such projects for Medtronic, and our look at Half Moon Medical, a Medtronic/The Foundry build-to-buy that is staking its claim in TMVR. We report from September’s in-person AAOS meeting, review the spate of funding for femtech start-ups, and talk with Keith Grossman about Nevro’s emergence as a force in SCS. Plus profiles of Valencell, Spiden, and UltraSight.
